NCT04985604 2025-10-02Tovorafenib (DAY101) Monotherapy for Patients With Melanoma and Other Solid TumorsDay One Biopharmaceuticals, Inc.Phase 2 Terminated23 enrolled 15 charts
NCT04704154 2025-04-18A Trial to Learn Whether Regorafenib in Combination With Nivolumab Can Improve Tumor Responses and How Safe it is for Participants With Solid TumorsBayerPhase 2 Completed175 enrolled 20 charts
NCT00788125 2023-07-14Dasatinib, Ifosfamide, Carboplatin, and Etoposide in Treating Young Patients With Metastatic or Recurrent Malignant Solid TumorsCity of Hope Medical CenterPhase 1/2 Terminated7 enrolled 9 charts
NCT01125800 2017-03-20A Phase I Dose Finding and Safety Study of Oral LDE225 in Children and a Phase II Portion to Assess Preliminary Efficacy in Recurrent or Refractory MBNovartisPhase 1/2 Completed76 enrolled 18 charts
NCT01132547 2015-07-02Cyproheptadine in Preventing Weight Loss in Children Receiving Chemotherapy for CancerUniversity of South FloridaPhase 3 Terminated22 enrolled 9 charts
NCT00538850 2014-03-05Fentanyl Sublingual Spray in Treating Patients With Breakthrough Cancer PainINSYS Therapeutics IncPhase 3 Completed130 enrolled 9 charts